http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180032538-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4cc7f48e39e2dc974993fb66a2c2c54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a82a85d8b540878975fb5ec5f8f53198 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-909 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 2018-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44e711c2a66baae06a502a6d57040370 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36be77bc5899ec89473462d7667ad1c3 |
| publicationDate | 2018-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20180032538-A |
| titleOfInvention | Composition for hypotonic lipolysis and manufacturing method thereof |
| abstract | The present invention discloses a storage fat decomposition composition and a process for its preparation. That is, the present invention provides a method for producing a sustained fat composition comprising deoxycholic acid, hyaluronidase and the like in a preservative solution composed of distilled water and sodium chloride, thereby improving the infusion site consolidation phenomenon caused by the use of deoxycholic acid alone And reduces the effects on cells containing other fat components other than adipocytes (including neurons, muscle cells, osteocytes, etc.) compared to deoxycholic acid alone, resulting in nerve palsy, muscle atrophy, (Adverse effect) such as edema, swelling, erythema, and pain, and by using hyaluronidase in combination with a preservative solution, fat cells It is possible to increase the efficiency of disruption and to use as an agent for reducing fat accumulated in the local region by subcutaneous administration. |
| priorityDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.